---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038029"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2023-10-24T23:59:59+00:00"
generated_at: "2026-06-09T13:50:42.779035+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics reduces stockholder quorum requirement from majority to one-third

## Summary
- Board approved Bylaw Amendment reducing quorum from majority to at least one-third of outstanding voting power.
- Amendment effective immediately as of October 20, 2023.
- Change intended to facilitate holding stockholder meetings with lower attendance threshold.

## SEC filing metadata
- accession: 0001493152-23-038029
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2023-10-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315223038029/0001493152-23-038029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315223038029/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038029
- JSON: https://secwatch.observer/filing/0001493152-23-038029.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038029.txt

## Key facts
- Governance Changes
  Bone Biologics Corp: Reduced quorum requirement for stockholder meetings from majority to at least one-third in voting power (effective 2023-10-20).
  - Change: bylaw amendment
  - Effective: 2023-10-20
  source text: On October 20, 2023, the Board of Directors of Bone Biologics Corporation (the “Company”) approved an amendment to the Company’s Amended and Restated Bylaws (the “Amendment”). The Amendment, which became effective immediately, reduces the quorum requirement at all meetings of the Company’s stockholders from a majority in voting power of the Company’s common stock issued and outstanding and entitled to vote at the meeting to at least one-third in voting power of the Company’s common stock issued and outstanding and entitled to vote at the meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315223038029/0001493152-23-038029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.